Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Radiology|March 1, 1988
Campylobacter ileocolitis mimicking acute appendicitis: differentiation with graded-compression USJ B Puylaert, R I Lalisang, S D van der Werf, et al.Bone Marrow Transplantation|March 7, 1998
High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodesR I Lalisang, P S Hupperets, M A ten Haaft, et al.Radiology|August 1, 1987
Radiation appendicitis: demonstration with graded compression USJ B Puylaert, F Hoekstra, B C de Vries, et al.Bone Marrow Transplantation|July 28, 2009
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancerA J H M Fleskens, R I Lalisang, G M J Bos, et al.Critical Reviews in Oncology/Hematology|May 9, 2022
The role of multimodal adjuvant therapy for FIGO I-II carcinosarcoma of the uterus: a systematic reviewR L van der Horst, O van der Hel, L Lutgens, et al.Annals of Hematology|April 26, 2001
Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based studyF P Peters, R I Lalisang, M M Fickers, et al.Gynecologic Oncology|July 14, 2018
Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancerM Timmermans, M A van der Aa, R I Lalisang, et al.The New England Journal of Medicine|September 10, 1987
A prospective study of ultrasonography in the diagnosis of appendicitisJ B Puylaert, P H Rutgers, R I Lalisang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancerR I Lalisang, J A Wils, H W Nortier, et al.British Journal of Cancer|June 23, 2000
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancerR I Lalisang, E E Voest, J A Wils, et al.Pageof 3